rs11584383
From SNPedia
| Orientation | plus |
| Stabilized | plus |
| Make rs11584383(C;C) |
| Make rs11584383(C;T) |
| Make rs11584383(T;T) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 1 |
| Position | 200966738 |
| Gene | MROH3P |
| is a | snp |
| is | mentioned by |
| dbSNP | rs11584383 |
| dbSNP (classic) | rs11584383 |
| ClinGen | rs11584383 |
| ebi | rs11584383 |
| HLI | rs11584383 |
| Exac | rs11584383 |
| Gnomad | rs11584383 |
| Varsome | rs11584383 |
| LitVar | rs11584383 |
| Map | rs11584383 |
| PheGenI | rs11584383 |
| Biobank | rs11584383 |
| 1000 genomes | rs11584383 |
| hgdp | rs11584383 |
| ensembl | rs11584383 |
| geneview | rs11584383 |
| scholar | rs11584383 |
| rs11584383 | |
| pharmgkb | rs11584383 |
| gwascentral | rs11584383 |
| openSNP | rs11584383 |
| 23andMe | rs11584383 |
| SNPshot | rs11584383 |
| SNPdbe | rs11584383 |
| MSV3d | rs11584383 |
| GWAS Ctlg | rs11584383 |
| GMAF | 0.169 |
| Max Magnitude | 0 |
| ? | (C;C) (C;T) (T;T) | 28 |
|---|---|---|
|
| ||
| GWAS snp | |
|---|---|
| PMID | [PMID 18587394 ]
|
| Trait | Crohn's disease |
| Title | Genome-wide assocation defines more than 30 distinct susceptibility loci for Crohn's disease |
| Risk Allele | T |
| P-val | 9.9999999999999994E-12 |
| Odds Ratio | 1.18 [NR] |
| GWAS snp | |
|---|---|
| PMID | [PMID 20228799]
|
| Trait | Ulcerative colitis |
| Title | Genome-wide association identifies multiple ulcerative colitis susceptibility loci |
| Risk Allele | T |
| P-val | 2E-7 |
| Odds Ratio | 1.27 [NR] |
[PMID 19068216] Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship.
[PMID 20007504] Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci.
[PMID 21304977] An investigation of genome-wide studies reported susceptibility loci for ulcerative colitis shows limited replication in north Indians.
[PMID 29967744] Association of Crohn's disease-related chromosome 1q32 with ankylosing spondylitis is independent of bowel symptoms and faecal calprotectin.
